InfuSystem (INFU) director Shuda awarded 24,890 options, reports direct and indirect holdings

Rhea-AI Filing Summary

InfuSystem Holdings director Scott Shuda received a new stock option grant and reported his share holdings. He was granted options for 24,890 shares of common stock at an exercise price of $8.37 per share, expiring on May 12, 2036. The option represents the right to buy 24,890 shares and vests on May 12, 2027.

After these updates, Shuda holds 94,000 shares of common stock directly and 298,383 shares indirectly through Meridian OHC Partners, LP and BlueLine Capital Partners II, over which he has voting and dispositive power. He disclaims beneficial ownership of the shares held by Meridian and BlueLine for purposes of Rule 13d-3.

Insights

Equity compensation analyst

Routine director option grant with clear vesting and long-dated expiry.

InfuSystem Holdings granted director Scott Shuda stock options for 24,890 shares at an exercise price of $8.37, vesting on May 12, 2027 and expiring on May 12, 2036. This is classified as a grant or award, not an open-market purchase.

The filing also lists 94,000 shares held directly and 298,383 shares held indirectly via Meridian and BlueLine, where Shuda has voting and dispositive power but disclaims beneficial ownership under Rule 13d-3. These entries appear as updated holdings rather than new market trades.

Overall, this looks like standard equity-based compensation and ownership reporting for a director, with no large buy or sell transactions disclosed. Future company filings may provide additional context on how these awards fit into broader director compensation practices.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Shuda Scott

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	24,890	$0.00	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 24,890 shares (Direct, null); Common Stock — 298,383 shares (Indirect, Footnote 1); Common Stock — 94,000 shares (Direct, null)

Footnotes (1)

1. Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II ("BlueLine"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine. The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.

Key Figures

Option grant size: 24,890 shares Option exercise price: $8.37 per share Option vesting date: May 12, 2027 +3 more

6 metrics

Option grant size 24,890 shares Stock option (right to buy) granted to director

Option exercise price $8.37 per share Exercise price for newly granted options

Option vesting date May 12, 2027 Vesting date for 24,890-share option grant

Option expiration date May 12, 2036 Expiration of director stock option grant

Direct share holdings 94,000 shares Common stock held directly after reported transactions

Indirect share holdings 298,383 shares Common stock held indirectly via Meridian and BlueLine

Key Terms

Stock Option (right to buy), Grant, award, or other acquisition, voting and dispositive power, beneficial ownership, +1 more

5 terms

Stock Option (right to buy) financial

"security_title: "Stock Option (right to buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

voting and dispositive power financial

"Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock"

beneficial ownership financial

"Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Rule 13d-3 regulatory

"disclaims beneficial ownership for purposes of Rule 13d-3"

Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shuda Scott

(Last) (First) (Middle)

C/O INFUSYSTEM HOLDINGS, INC.

3851 WEST HAMLIN ROAD

(Street)

ROCHESTER HILLS MICHIGAN 48309

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InfuSystem Holdings, Inc [ INFU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								298,383	I	Footnote 1(1)
Common Stock								94,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$8.37	05/12/2026		A		24,890		05/12/2027(2)	05/12/2036	Common Stock	24,890	$0	24,890	D

Explanation of Responses:

1. Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II ("BlueLine"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine.

2. The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.

Remarks:

	/s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did InfuSystem (INFU) director Scott Shuda receive in this Form 4 filing?

Director Scott Shuda received a stock option grant for 24,890 shares of InfuSystem common stock at an exercise price of $8.37 per share. The option is a compensation-related award, not an open-market purchase, and provides the right to buy shares if exercised in the future.

When do Scott Shuda’s new InfuSystem (INFU) stock options vest and expire?

The option grant for 24,890 shares of InfuSystem common stock vests on May 12, 2027. It carries an expiration date of May 12, 2036, giving a long time window during which the director can choose to exercise the options, subject to conditions.

How many InfuSystem (INFU) shares does Scott Shuda hold directly and indirectly?

After the reported transactions, Scott Shuda holds 94,000 InfuSystem common shares directly. He also reports indirect ownership of 298,383 shares through Meridian OHC Partners, LP and BlueLine Capital Partners II, over which he has voting and dispositive power as managing director.

What does Scott Shuda’s Rule 13d-3 beneficial ownership disclaimer mean for INFU?

The filing states that Shuda disclaims beneficial ownership under Rule 13d-3 for shares held by Meridian and BlueLine. This means that, although he has voting and dispositive power over those shares, he does not treat them as personally owned for that specific regulatory ownership definition.

Is this InfuSystem (INFU) Form 4 a buy or sell transaction by Scott Shuda?

The Form 4 primarily reports a stock option grant classified as a grant, award, or other acquisition, not an open-market buy or sell. Additional lines show updated direct and indirect share holdings without indicating explicit purchase or sale transactions in the reported data.